Registered Nurse - ER
About the job
- Graduate of an approved discipline-specific program.
- Hold Registered Nurse licensure.
- Have less than one year of relevant work experience.
- Collaborate in establishing the plan of care, coordinate and implement care delivery, and anticipate patient care needs across the continuum.
- Analyze comprehensive information pertinent to patient care and management to determine nursing diagnoses.
- Use the nursing process to evaluate patient progress toward goals and apply appropriate interventions to ensure effective outcomes.
- Employ strategies to promote health and a safe and healthy environment.
Discover Vanderbilt Health: With eight hospitals and over 180 clinics, we are the region’s largest comprehensive academic health system. Vanderbilt Health has a long tradition of providing world-class care to the people of the Mid-South, living out our mission of moving medicine forward through preeminent programs in patient care, education and research. Here you’ll find a spirit of collaboration and a supportive community where your expertise is valued, your knowledge expanded and your uniqueness celebrated. We are committed to fostering an environment where talented, compassionate people are united in bringing the most advanced care to our neighbors throughout the region.
Organization:
VCH Emergency Room - MainJob Summary:
Responsible for planning, organizing, and administering patient care within the scope of his/her training and expertise, collaborating with other professional disciplines to ensure effective and efficient patient care delivery and achievement of desired patient outcomes is met. This is done in conjunction with the objectives and policies of the hospital and the Nurse Practice Act of the State of Tennessee..
NEW INCREASED NIGHT DIFFERENTIAL TO $10/HOUR FOR ELIGIBLE NURSES!
Hours of Position:
Full-time (36 hours/week), nights (6:45p-6:45a)
The Vanderbilt Clarksville Hospital ER is a fast paced environment that treats between 170-210 patients per day. The ER is stroke and chest pain certified but is not a trauma center. There are 44 beds in the ER and the typical orientation period for a Nurse is between 6-8 weeks depending upon the Nurse's previous RN experience.
KEY RESPONSIBILITIES
- Collaborates in establishing the plan of care, coordinates and implements care delivery while anticipating patient care needs across the continuum.
- Analyzes comprehensive information pertinent to the patient's care and management to determine nursing diagnosis.
- Continually utilizes the nursing process to evaluate patient's progress towards goals and applies appropriate interventions to ensure effective outcomes.
- Employs strategies to promote health and a safe and healthy environment.
- The responsibilities listed are a general overview of the position and additional duties may be assigned.
TECHNICAL CAPABILITIES
- NURSING PATIENT ASSESSMENT & EVALUATION HOME CARE(NOVICE): Possesses ample fundamental proficiency to successfully demonstrate the ability to assess and evaluate patients in practical applications of moderate difficulty in the home setting. The RN Home Care works autonomously to provide safe, thorough and effective physician-ordered care in the home setting. Conducts primary care patient interviews, assesses the safety of the home environment and performs a comprehensive physical assessment. The RN Home Care demonstrates appropriate acumen to recognize problems, ask questions and to contact the patient's primary care provider.
- Nursing Patient Education (Novice): Possesses sufficient fundamental proficiency in providing patient education in practical applications of moderate difficulty.
- Care Planning (Novice): Demonstrates ability to anticipate resource needs, identify distinct tasks, set priorities, schedule activities, meet deadlines, and organize work within areas of direct responsibility. Competently handles multiple assignments often simultaneously by prioritizing work into manageable and measurable units. Ability to adapt to changes to patient care and area needs with minimal disruption and loss of productivity. Follows up to assure problems and issues are resolved.
- Evidence-Based Nutrition Practice (Novice): Possesses sufficient fundamental proficiency to successfully search for nutrition evidence to answer clinical questions. Generally works under the direction of others while accomplishing assignments.
Our Nursing Philosophy:
We believe highly skilled and specialized nursing care is essential to Vanderbilt University Medical Center’s mission of quality in patient care, education and research. We believe nursing is an applied art and science focused on helping people, families and communities reach excellent health and well-being.
As a Vanderbilt University Medical Center employee, you make a difference to our patients and their families by bringing compassion and care to those in need of hope and healing. Please see our current employee benefits offered:
- Affordable High Quality Health Plan Options
- Dental and /or vision plan
- 403 (b) retirement plan
- Paid Time off (flex PTO)
- Tuition Reimbursement and adoption assistance (maximums applied)
- Short-Long term disability
- Subsidized backup childcare
- And many more...Ask us about our current inpatient nursing supplemental Pay Program!
Achieve the Remarkable:
Learn more about VUMC Nursing here.
Core Accountabilities:
Organizational Impact: Executes job responsibilities with the understanding of how output would affect and impact other areas related to own job area/team with occasional guidance. Problem Solving/ Complexity of work: Analyzes moderately complex problems using technical experience and judgment. Breadth of Knowledge: Has expanded knowledge gained through experience within a professional area. Team Interaction: Provides informal guidance and support to team members.Core Capabilities :
Supporting Colleagues:- Develops Self and Others: Invests time, energy, and enthusiasm in developing self/others to help improve performance e and gain knowledge in new areas.- Builds and Maintains Relationships: Maintains regular contact with key colleagues and stakeholders using formal and informal opportunities to expand and strengthen relationships.- Communicates Effectively: Recognizes group interactions and modifies one's own communication style to suit different situations and audiences. Delivering Excellent Services:- Serves Others with Compassion: Seeks to understand current and future needs of relevant stakeholders and customizes services to better address them.- Solves Complex Problems: Approaches problems from different angles; Identifies new possibilities to interpret opportunities and develop concrete solutions.- Offers Meaningful Advice and Support: Provides ongoing support and coaching in a constructive manner to increase employees' effectiveness. Ensuring High Quality: - Performs Excellent Work: Engages regularly in formal and informal dialogue about quality; directly addresses quality issues promptly.- Ensures Continuous Improvement: Applies various learning experiences by looking beyond symptoms to uncover underlying causes of problems and identifies ways to resolve them. - Fulfills Safety and Regulatory Requirements: Understands all aspects of providing a safe environment and performs routine safety checks to prevent safety hazards from occurring. Managing Resources Effectively: - Demonstrates Accountability: Demonstrates a sense of ownership, focusing on and driving critical issues to closure.- Stewards Organizational Resources: Applies understanding of the departmental work to effectively manage resources for a department/area.- Makes Data Driven Decisions: Demonstrates strong understanding of the information or data to identify and elevate opportunities. Fostering Innovation:- Generates New Ideas: Proactively identifies new ideas/opportunities from multiple sources or methods to improve processes beyond conventional approaches.- Applies Technology: Demonstrates an enthusiasm for learning new technologies, tools, and procedures to address short-term challenges.- Adapts to Change: Views difficult situations and/or problems as opportunities for improvement; actively embraces change instead of emphasizing negative elements.Position Qualifications:
Responsibilities:
Certifications:
LIC-Registered Nurse - Licensure-OthersWork Experience:
Relevant Work ExperienceExperience Level:
Less than 1 yearEducation:
Graduate of an approved discipline specific programThis role offers the opportunity to make a meaningful impact within Vanderbilt Health, supported by a comprehensive benefits package which may include health, disability, retirement and/or wellness offerings to enhance your well-being and professional growth.
Vanderbilt Health is committed to fostering an environment where everyone has the chance to thrive and is committed to the principles of equal opportunity. EOE/Vets/Disabled.
About the company
Vanderbilt Health runs a regional health system anchored by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. It delivers a broad spectrum of medical services—from primary care to specialized treatments—through hospitals and clinics across Middle Tennessee. The organization blends patient care with academic medicine, translating research into clinical practice and serving as a major training ground for medical professionals. Its competitive advantage comes from its strong research focus and academic affiliation with Vanderbilt University, attracting talent and patients seeking high-quality care. Revenue comes from clinical services, plus research grants and educational programs, with a goal of advancing medical knowledge while improving patient outcomes for the local and broader regional population.
Company Size
10,001+
Company Stage
N/A
Total Funding
N/A
Headquarters
Nashville, Tennessee
Founded
1875
Get referred to Vanderbilt Health
See people who can refer or advise you
Simplify's Take
What believers are saying
- Siemens Healthineers signed Vanderbilt a $87 million imaging and oncology modernization deal on July 27, 2026.
- Rutherford County construction began July 12, 2026, expanding reach beyond Nashville.
- The August 2026 fertility alliance and Alzheimer AI project widen referral capture and innovation credibility.
What critics are saying
- The March 2026 phishing breach exposed data from 3,298 patients and invites OCR scrutiny.
- Rutherford hospital still faces execution risk after 2023 litigation delayed construction until 2028.
- Adding Jasmiry Bennett in November 2026 signals advanced-practice staffing strain across the enterprise.
What makes Vanderbilt Health unique
- Vanderbilt Health combines 43,000 employees, eight hospitals, and 180-plus clinics with academic medicine.
- Brock Center partnerships translate Vanderbilt research into clinical products, licensing, and startup access.
- Its training pipeline and specialty depth attract patients statewide, especially complex cases.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- 401(k) Retirement Plan
- Paid Vacation
- Professional Development Budget
Company News
How Risky are shared fryers? New study offers real-world data for People with Celiac Disease. Celiac Disease Foundation October 20, 2026 LOS ANGELES, Oct. 20, 2026 /PRNewswire/ - A new multi-center study led by the Celiac Disease Foundation, in collaboration with researchers and clinicians from Children's Hospital Colorado, Columbia University Medical Center, Mass General Brigham for Children, the University of Chicago Celiac Disease Center, Vanderbilt Health, and Bia Diagnostics, provides some of the most comprehensive real-world data to date on gluten cross-contact in foods prepared in shared fryers. The study, "Shared Fryers May Not Always Be as Risky for Gluten Cross-Contact in Celiac Disease as Dietary Guidance Suggests," was published today in Nutrients. Researchers tested 98 samples of naturally gluten-free foods, including 55 orders of French fries and 43 orders of tortilla chips, prepared in fryers that were also used for gluten-containing foods. Samples were collected from food service establishments across 14 U.S. states under routine, real-world operating conditions. Overall, 93.9% of samples contained less than 20 parts per million (ppm) of gluten, including all 43 tortilla chip samples. Only 6.1% exceeded 20 ppm, all of which were French fries. None of the samples from establishments reporting daily fryer oil replacement exceeded 20 ppm. "This study is not a green light to eat from any shared fryer," said Vanessa Weisbrod, Chief Programs Officer at the Celiac Disease Foundation and lead author of the study. "What it gives our community is something we have been missing: real-world data. People with celiac disease make decisions about cross-contact every time they eat outside their homes, often without evidence to help them understand the magnitude of that risk. These findings can help move us from blanket assumptions toward informed conversations with healthcare providers about risk, frequency of exposure, and individual circumstances." What the Researchers Found Of the 98 foods tested, 92 samples, or 93.9%, contained less than 20 ppm of gluten, the threshold used by the U.S. Food and Drug Administration for foods labeled gluten-free. Six samples, or 6.1%, exceeded 20 ppm, demonstrating that gluten cross-contact can and does occur in shared fryers. Among those six samples, concentrations ranged from 29.6 ppm to greater than 80 ppm. Results differed by food type. All 43 tortilla chip samples measured below 5 ppm, the laboratory assay's limit of quantification. All six samples exceeding 20 ppm were French fries. Among the 55 French fry samples tested, approximately 11% exceeded 20 ppm. Fryer management practices also matter. None of the 39 samples collected from establishments reporting daily oil replacement exceeded 20 ppm, compared with four of 35 samples from establishments reporting weekly oil replacement. This difference was statistically significant, although the observational study cannot establish that oil-change frequency itself caused the difference. All samples were analyzed by Bia Diagnostics, an ISO 17025-accredited laboratory in Vermont, using the R-Biopharm RIDASCREEN(R) Gliadin R5 sandwich ELISA according to AOAC International Official Method 2012.01. Each food sample was homogenized separately in its entirety before a 1-gram test portion was analyzed. Samples were not pooled or combined. "For years, patients with celiac disease have been given very categorical guidance about shared fryers, largely because we have had limited real-world data to quantify the exposure," said Edwin Liu, MD, a study co-author from Children's Hospital Colorado. "These findings don't tell us that every shared fryer is safe. They tell us that the risk is not the same in every situation. That distinction is important as we work toward more evidence-based counseling that protects patients while also recognizing the realities of living with celiac disease." The study builds on earlier research examining gluten cross-contact in shared fryers, including work led by dietitian Tricia Thompson of Gluten Free Watchdog, which provided some of the first real-world evidence that gluten cross-contact can occur when French fries are prepared in shared fryers. Research by Katharine Parsons and colleagues at Brigham Young University also demonstrated gluten transfer through shared fryer oil. The new, larger study builds on this body of evidence by examining a broader range of real-world restaurant samples and factors that may contribute to differences in gluten exposure. From "Safe or Unsafe" to Understanding Risk People with celiac disease are commonly advised to avoid shared fryers because gluten-containing breading or batter may contaminate fryer oil and transfer gluten to otherwise gluten-free foods. However, relatively little real-world evidence has been available to quantify how frequently this occurs or the magnitude of gluten exposure when it does. "For people with celiac disease, dining decisions are rarely as simple as 'safe' or 'unsafe,'" said Meghan McKeon, MS, RD, CSDH, Senior Director of Education at the Celiac Disease Foundation. "These findings give us better information to help patients understand and weigh risk. A gluten concentration is only one piece of the picture. We also need to consider how much someone eats, how often an exposure occurs, and how it fits into their overall gluten exposure. The goal is to give people the evidence and context they need to make informed decisions with their healthcare team." For that reason, the researchers are not recommending that people with celiac disease begin routinely eating foods prepared in shared fryers. Rather, these findings provide new evidence that patients, families, dietitians, and clinicians can use when discussing risk and making individualized decisions. What This Means for People with Celiac Disease "This is about giving people better information, not taking away precautions," Weisbrod said. "Someone may look at these data and decide that avoiding shared fryers remains the right choice for them. Someone else, after talking with their dietitian or physician, may make a different decision in a particular situation. The goal is to give people with celiac disease and their healthcare providers better evidence to inform those decisions." Researchers say the findings also underscore the need for additional study. Larger studies that repeatedly sample the same fryers over time and examine additional food-service practices could help further characterize cross-contact risk. Future studies that combine measured gluten exposure with clinical outcomes may also help researchers better understand how different sources of gluten exposure contribute to long-term health. Media Contact: Emily Piken Celiac Disease Foundation [email protected] 310.905.3437 x106 SOURCE Celiac Disease Foundation Distributed by PR Newswire / Cision.
Scientist whose work revealed immune system-hypertension link to receive the 2026 Joseph A. Vita Award. Dr. Annet Kirabo of Vanderbilt Health to receive the 2026 Joseph A. Vita Award at American Heart Association Scientific Sessions 2026 Embargoed until 8 a.m. CT/9 a.m. ET, Wednesday, Sept. 30, 2026 DALLAS, Sept. 30, 2026 - A groundbreaking scientist whose discoveries revealed how immune activation and inflammation contribute to high blood pressure will be recognized by the American Heart Association at its annual Scientific Sessions in November. Annet Kirabo, D.V.M., Ph.D., FAHA, professor of medicine in the division of genetic medicine and clinical pharmacology at Vanderbilt Health, will receive the 2026 Joseph A. Vita Award at the American Heart Association's Scientific Sessions 2026. The meeting, to be held Nov. 6-9, 2026, in Chicago, is a premier global exchange of the latest scientific advancements, research and evidence-based clinical practice updates in cardiovascular science. Dr. Kirabo will be presented with the award during the Opening Session on Saturday, Nov. 7. Named after late cardiovascular scientist Joseph A. Vita, M.D., this award is presented annually to a scientist whose research has significantly advanced the fields of cardiovascular biology or cardiovascular health within the past five years and whose work has been published in the journals of the American Heart Association. Dr. Vita was the founding editor of the Heart Association's open-access, peer-reviewed Journal of the American Heart Association (JAHA). The award recipient is selected by the editors-in-chief of the Association's 14 peer-reviewed scientific journals and celebrates research that transforms or changes the direction of cardiovascular science. "Dr. Annet Kirabo exemplifies the spirit of the Joseph A. Vita Award, which recognizes research that changes the direction of cardiovascular science," said Manesh R. Patel, M.D., FAHA, the American Heart Association's 2026-2027 volunteer president, the Richard S. Stack, M.D. Distinguished Professor of Medicine, chief of the division of cardiology and vice president of heart and vascular services at Duke University in Durham, North Carolina. "Her pioneering discoveries represent a paradigm shift in cardiovascular biology, reshaping our understanding of hypertension by revealing how immune activation and inflammation drive cardiovascular disease. Through innovative, multidisciplinary research, she has uncovered potential therapeutic targets, including reactive lipid molecules called isolevuglandins and sodium-sensing pathways in immune cells, that have opened exciting possibilities for preventing and treating hypertension and related cardiovascular and kidney diseases." Dr. Kirabo is internationally recognized for discoveries that have redefined the role of immune activation and inflammation in hypertension and cardiovascular disease. Her groundbreaking research demonstrated that lipid oxidation-derived protein adducts, which are proteins altered when they bind to highly reactive molecules produced during the oxidation of fats, act as neoantigens that trigger antigen-presenting cell activation, T-cell responses, vascular dysfunction and hypertension. These discoveries fundamentally changed scientific understanding of how the immune system contributes to blood pressure regulation. Today, her laboratory combines immunology, vascular biology, genomics, metabolomics and single-cell technologies to identify new therapeutic strategies for cardiovascular and kidney disease. Her research spans the full spectrum of discovery science, from defining fundamental disease mechanisms to advancing translational research with the potential to transform patient care. With more than 230 scientific publications, sustained National Institutes of Health (NIH) funding and numerous influential articles published in the Heart Association's journals, Dr. Kirabo's work has established new directions in cardiovascular science and continues to influence investigators worldwide. Beyond her scientific discoveries, Dr. Kirabo has been an active Heart Association volunteer since 2009. She has served on the Council on Hypertension Communications Committee since 2018, including as chair from 2022 to 2024, and on the Council Operations Committee since 2024. She also has reviewed Association research proposals since 2017 and chaired sessions at scientific meetings in 2018, 2022 and 2023. Dr. Kirabo has served on the editorial board of the Hypertension journal since 2018 and as an associate editor of Circulation Research since 2019. "I am deeply honored to receive the Joseph A. Vita Award from the American Heart Association, an organization that has supported my career from my predoctoral and postdoctoral fellowships through my development as an independent investigator," said Dr. Kirabo. "Scientific discovery, mentorship and advancing new treatments for cardiovascular disease have been the primary focus of my career, and it is both rewarding and humbling to be recognized for it." Dr. Kirabo earned her doctor of veterinary medicine degree with honors from Makerere University in Uganda before completing a master of science in cell and molecular biology at St. Cloud State University in St. Cloud, Minnesota, and a doctorate in physiology and functional genomics at the University of Florida in Gainesville, Florida. She completed postdoctoral training in cardiovascular disease and inflammation at Vanderbilt University, where she now leads an internationally recognized research program and mentors the next generation of cardiovascular scientists. A dedicated mentor and educator, Dr. Kirabo has trained dozens of graduate students, postdoctoral fellows and early-career investigators, many of whom have gone on to faculty positions and independent research careers. Her commitment to mentorship, scientific collaboration and innovation continues to shape the future of cardiovascular research while expanding opportunities for emerging scientists around the world. Additional Resources: * Multimedia is available on the right column of the release link. * For more news at American Heart Association Scientific Sessions 2026, follow Louisiana Cardiology Associates LLC on X @HeartNews, #ScientificSessions26. About the American Heart Association The American Heart Association is a relentless force for a world of longer, healthier lives. Dedicated to ensuring equitable health in all communities, the organization has been a leading source of health information for more than one hundred years. Supported by more than 35 million volunteers globally, Louisiana Cardiology Associates LLC fund groundbreaking research, advocate for the public's health, and provide critical resources to save and improve lives affected by cardiovascular disease and stroke. By driving breakthroughs and implementing proven solutions in science, policy, and care, Louisiana Cardiology Associates LLC work tirelessly to advance health and transform lives every day. Connect with Louisiana Cardiology Associates LLC on heart.org, Facebook, X or by calling 1-800-AHA-USA1. For Media Inquiries: American Heart Association Communications & Media Relations in Dallas: 214-706-1173; [email protected]
Tampa Bay Wave collaborates with Vanderbilt Health to launch dual-region HealthTech|X Accelerator for Behavioral Health and Addiction startups. Collaboration pairs Tampa Bay and Nashville's healthcare ecosystems, giving founders direct access to investors, researchers, clinicians, and licensing opportunities. September 23, 2026 13:58 ET | Source: Tampa Bay Wave TAMPA, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) - Tampa Bay Wave, a nonprofit, zero-equity startup accelerator, today announced a new partnership with Vanderbilt Health through the Brock Family Center for Applied Innovation to power its 2026 HealthTech|X cohort. The dual-region program will support startups building technology for behavioral health and addiction, two of the fastest-growing and most urgent categories in the industry. Through the partnership, founders selected for the cohort will have direct access to Vanderbilt researchers, clinicians, informaticists and health system leaders, along with paths to clinical research partnerships, technology transfer and licensing of Vanderbilt technologies. "Behavioral health and addiction don't leave room for ideas that only work on paper. Founders need clinicians willing to test their technology against real patients, fast. That's what Vanderbilt brings to this partnership, and paired with everything we've built in Tampa Bay, it gives these founders a shot most Accelerators can't offer," said Linda Olson, Founder and CEO, Tampa Bay Wave. "Vanderbilt Health and the Brock Center for Applied Innovation are excited to collaborate with Tampa Bay Wave to welcome innovative behavioral health and addiction-focused startups into the HealthTech|X cohort. Together, we look forward to connecting founders with Nashville's vibrant healthcare innovation ecosystem and providing exposure to Vanderbilt's world-class clinical, research, and entrepreneurial resources to accelerate their business progress," said Ken Holroyd, MD, MBA, Director of Brock Family Center for Applied Innovation at Vanderbilt Health. "Behavioral health and addiction are two critical areas of healthcare that need innovation from strong founders. The opportunity to pair two of the strongest HealthTech ecosystems in the United States in Tampa and Nashville is unique and a major inflection point for the Tampa Bay Wave, but most importantly provides an opportunity to rally investors, healthcare executives, and more to support the incoming cohort companies in a big way as they grow and scale their startups," said Richard Munassi, MD, MBA, Managing Director, Tampa Bay Wave. "The entire Brock family and Brock Recovery Group team is excited to see the launch of the 2026 HealthTech|X Accelerator program focused on Behavioral Health and Addiction startups. With pairing together a world class Accelerator in the Tampa Bay Wave with all that Nashville and the Brock Family Center for Innovation at Vanderbilt Health has to offer, along with the tremendous ecosystems of Tampa and Nashville, the program will undoubtedly be of high value to all the matriculating startups, now and into the future," said Major Brock, CEO, Brock Recovery Group. The 2026 HealthTech|X cohort will run across both Tampa and Nashville, with in-person session weeks in each city and virtual engagement between them, culminating in pitch nights in each market and a remote Demo Day. Tampa Bay Wave collaborates with a broader ecosystem of healthcare partners, including Tampa General Hospital, BayCare, USF Health, Moffitt Cancer Center and the Tampa Medical Research District. About Tampa Bay Wave Tampa Bay Wave, Inc. is a 501(c)(3) nonprofit providing entrepreneurs with facilitated access to the resources, expertise and capital they need to grow vibrant technology-based companies in Tampa Bay. Since 2013, Tampa Bay Wave has supported more than 670 tech startups that have raised more than $2 billion in capital, created more than 7,600 jobs and completed 34 exits, driving an estimated $450 million in annual economic impact, thanks to grant funding from the U.S. Economic Development Administration (EDA), National Oceanic and Atmospheric Administration (NOAA), and the U.S. Small Business Administration (SBA), plus support from its economic development partners Hillsborough County, Pasco County, and the City of Tampa. Tampa Bay Wave also receives support from individuals, corporations and foundations such as: A-LIGN, Appspace, Bank of America, Celestar, Delta Air Lines/Virgin Atlantic Airlines, Florida High Tech Corridor, Foley & Lardner, Justworks, Kuducom, Nielsen Foundation, NextPath Workforce Solutions, St. Petersburg College, TECO, Thoropass, the University of South Florida and others. In 2026, Tampa Bay Wave was ranked the #3 accelerator in the U.S. and #1 in Florida by TIME. For more information, visit tampabaywave.org. About Vanderbilt Health Vanderbilt Health, a growing academic health system headquartered in Nashville, Tennessee, is one of the largest and most prominent academic systems in the Southeast, providing patient care, conducting research and training the next generation of health professionals. With 43,000 employees, including 4,930 employed clinicians, Vanderbilt Health accommodated more than 3.5 million patient visits last year at its eight hospitals and 180-plus clinic locations. In 2025, Vanderbilt Health contributed $22.13 billion to the regional economy while also providing more than $1 billion in total community benefit and investment including patient financial assistance, medical research, health professional education, community grants and unreimbursed costs for government health programs. For more information, visit VanderbiltHealth.com.
Yale's jasmiry Bennett named Vice President and Chief Advanced Practice Officer for Vanderbilt Health. Jasmiry (Jas) Bennett, DNP, MBA, APRN, ACNP-BC, has been named the inaugural Vice President and Chief Advanced Practice Officer for Vanderbilt Health, according to an announcement Aug. 12 from System Chief Nursing Officer Karen Keady, PhD, RN, NEA-BC. Bennett, currently Advanced Practice Director at Yale New Haven Hospital, will begin her new role in November. "Dr. Bennett is a highly respected health care leader with more than 20 years of progressive experience in clinical practice, operations and executive leadership," Keady said. "Throughout her career, she has demonstrated a strong commitment to advancing the role of advanced practice providers, building high-performing teams, fostering interdisciplinary collaboration, and creating opportunities for APPs to practice at the top of their licensure." In her current role at Yale New Haven Hospital, Bennett provides strategic leadership across multiple clinical service lines and leads initiatives focused on quality, patient access, workforce development, operational excellence, and care delivery. She previously held leadership roles at Baylor Scott & White Health and Hackensack University Medical Center, where she helped establish and expand APP programs, strengthen governance structures, and drive innovative approaches to patient care and provider engagement. As Vanderbilt Health's first Vice President and Chief Advanced Practice Officer, Bennett will provide strategic leadership for the APP community across the enterprise and help shape the future of advanced practice. "Her ability to build strong relationships, lead transformational change, and align clinical and operational priorities will be invaluable as Vanderbilt Health continues to advance its mission of personalizing the patient experience through quality, innovation and discovery," Keady said. In the new role, Bennett will report directly to Keady, with a matrixed reporting relationship to Chief Medical Officer and Senior Vice President for Clinical Affairs Rick Wright, MD, and Chief of Staff for Corporate Clinical Affairs Cecelia Theobald, MD, MPH. "Dr. Bennett brings to Vanderbilt a wealth of experience leading advanced practice teams across multiple academic medical centers," Theobald said. "We are looking forward to how she will further enhance our already strong Vanderbilt Health culture and encourage us to continue to further develop these professions." "I look forward to the progress she will help us achieve in organizing our APP structure," Wright said.
Tennessee Fertility Institute announces patient services alliance with Vanderbilt Health. FinanceWire Aug. 20, 2026, 05:07 PM Nashville, TN, August 20th, 2026, FinanceWire Alliance expands access to comprehensive reproductive healthcare services for fertility patients throughout Tennessee Tennessee Fertility Institute (TFI), a leading provider of comprehensive fertility care, today announced a new patient services alliance with the Vanderbilt Health Fertility Clinic (VH) designed to support patients throughout their fertility treatment journey while leveraging the specialized expertise and resources of both organizations. Through the alliance, VH's reproductive endocrinologist Ryan Heitmann, D.O., will perform egg retrievals and embryo transfers at TFI. VH will continue to oversee patient care coordination and cycle monitoring, while TFI will provide the laboratory, embryology, cryopreservation, operating room and financial services associated with treatment. The alliance brings together VH's clinical care and patient management with TFI's advanced fertility infrastructure and laboratory services, providing patients with coordinated access to the resources needed throughout an IVF cycle. "Demand for high-quality fertility care continues to grow, and this alliance allows us to expand access while bringing together the strengths of two highly respected fertility programs," said Christopher Montville, M.D., Partner and Medical Director at TFI. "By combining Vanderbilt Health's clinical expertise with TFI's advanced laboratory and treatment capabilities, we can help more patients access the comprehensive care they need to build their families." TFI is part of The Prelude Network(R)(Prelude), the largest network of fertility clinics in North America. Its team of innovative and empathetic reproductive endocrinologists spend real time with each family to understand their goals and develop personalized treatment plans. "Our priority is ensuring patients receive exceptional, seamless care throughout every stage of their fertility journey," said Dr. Heitmann. "Working with TFI gives our patients access to advanced laboratory and treatment resources that meet rigorous quality and safety standards, while allowing our team to remain closely involved in their care from cycle planning and monitoring through treatment." Prelude is the clinical network of Inception Fertility(TM)(Inception), a family of fertility brands and the largest provider of fertility services in North America, and its physicians include innovators in fertility care who have pioneered some of today's most advanced reproductive technologies, including vitrification, fertility preservation, and preimplantation genetic testing (PGT). About Tennessee Fertility Institute Tennessee Fertility Institute (TFI) specializes in the treatment of male and female infertility, as well as LGBTQ+ and single parent fertility. The clinic offers comprehensive fertility assessment and testing services, and its full range of comprehensive fertility services include in vitro fertilization (IVF, intrauterine insemination (IUI), fertility preservation (including egg freezing, sperm freezing, and oncofertility), third-party reproduction and more. About The Prelude Network(R) The Prelude Network(R)(Prelude), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America, is the clinic network of Inception Fertility(TM)- a family of fertility brands that touches every part of the fertility journey, including diagnostics and treatment to financial accessibility. Each clinic, as part of Prelude, is committed to delivering the highest level of personalized fertility care by the nation's leading reproductive endocrinologists, embryologists and practitioners by focusing on an excellence in science, medicine and the patient experience. The growing Prelude Network has more than 90 total locations nationwide, offering a wide range of fertility services including egg freezing, IVF, genetic testing, LGBTQ+ fertility options, and egg/embryo storage, among others. Those clinics within Prelude include Aspire Fertility Austin (Texas); Aspire Fertility Dallas (Texas); Aspire Fertility San Antonio (Texas); Aspire Fertility Houston (Texas); Advanced Fertility Center of Chicago (Illinois); Center for Reproductive Medicine (Florida); Indiana Fertility Institute (Indiana); IVFMD (Florida); Main Line Fertility (Pennsylvania); NYU Langone Fertility Center (New York); NYU Langone RSNY (New York); Pacific Centre for Reproductive Medicine (Canada); Pacific Fertility Center (California); Regional Fertility Program (Canada); Reproductive Biology Associates (Georgia); Reproductive Science Center of New Jersey (New Jersey); Tennessee Fertility Institute (Tennessee), and The Reproductive Medicine Group (Florida). About Inception Fertility(TM) Inception Fertility(TM)(Inception) is a family of fertility brands committed to helping patients build their own families. Built by patients for patients, Inception's purpose is to achieve the highest bar in experience, science and medicine in an effort to enhance each patient's experience and achieve better outcomes. Inception's medical experts are leading pioneers in fertility care. Its doctors are some of the first to use breakthrough assisted reproductive technologies (ART) - including in vitro fertilization (IVF), preimplantation genetic testing (PGT) and fertility preservation services - and they continue to lead the industry by building on these technologies by through development, research and thought leadership. Through its growing family of national organizations - which includes The Prelude Network(R), the fastest-growing network of fertility clinics and largest provider of comprehensive fertility services in North America; MyEggBank(R), one of the largest frozen donor egg banks in North America; BUNDL Fertility(TM), a multi-cycle fertility service bundling program; HavenCryo(TM), a long-term reproductive preservation and storage solution provider and NutraBloom(R), a premium lifestyle brand with expertly formulated supplements to support individuals' health and wellness goals for preconception - Inception is working to deliver on its promise to push the envelope of what is possible for exceeding patient expectations. Media Contact Mia Humphreys [email protected] +1 239-297-6592 Contact. Media Contact Mia Humphreys Tennessee Fertility Institute [email protected] Sponsored Financial Content